Sickle cell disease landscape and challenges
Mariane de Montalembert Mariane de Montalembert PhD, head of the Hemoglobin Diseases Unit at the Necker University Hospital.
Sickle cell disease landscape and challenges Read More »
0.5 Credit
State of the Art Management of Follicular Lymphoma
Nilanjan Ghosh Nilanjan Ghosh, MD, PhD, oncologist in Charlotte, North Carolina and is affiliated with Atrium Health Carolinas Medical Center.
State of the Art Management of Follicular Lymphoma Read More »
Allogeneic Stem Cell Transplantation for Myelofibrosis
Ibrahim Yakoub-Agha Prof. Ibrahim Yakoub, professor for the Department of Hematology at Lille Faculty of Medicine. Editor in Chief of Current Research in Translational Medicine.
Allogeneic Stem Cell Transplantation for Myelofibrosis Read More »
Curative therapies for transfusion-dependent thalassemia (TDT)
Josu de la Fuente Josu de la Fuente PhD, is a Consultant Haematologist at Imperial College Healthcare NHS Trust and Professor of Practice (Cellular and Gene Therapies) at Imperial College London
Curative therapies for transfusion-dependent thalassemia (TDT) Read More »
Maintenance therapy after allogeneic stem cell transplantation for FLT3-ITD AML: current status and guidelines
Ali Bazarbachi Ali Bazarbachi MD, PhD is a Professor of Medicine (Hematology and Oncology), Anatomy, Cell Biology and Physiological Sciences. Founding Director of the bone marrow transplantation program at the American University of Beirut Medical Center.
DLI after allogeneic stem cell transplantation: where do we stand ?
Panagiotis Tsirigotis Panagiotis Tsirigotis practices in Athens, Greece. His expertise are Graft Versus Host Disease (GvHD), Pulmonary Alveolar Proteinosis, Non-Hodgkin Lymphoma, Leukemia, and Bone Marrow Transplant.
DLI after allogeneic stem cell transplantation: where do we stand ? Read More »
Aplastic anemia management : what’s new ?
Baldeep Wirk Baldeep Wirk MD, is a hematologist in Richmond, Virginia and is affiliated with with Penn State Health Milton S. Hershey Medical Center.
Aplastic anemia management : what’s new ? Read More »
Diagnosis and management of systemic mastocytosis: what’s new in 2024 ?
Prithviraj Bose Dr. Prithviraj Bose is a professor in the Department of Leukemia at the MD Anderson Cancer Center in Houston, TX.
Diagnosis and management of systemic mastocytosis: what’s new in 2024 ? Read More »
Pathology Made Easy for the Clinical Hematologist
Sanam Loghavi Sanam Loghavi is an Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at MD Anderson Cancer Center.
Pathology Made Easy for the Clinical Hematologist Read More »
Vaccination against COVID-19: Where do we stand ?
Eolia Brissot Eolia Brissot PhD, MD, is an Associate Professor in Hematology at the Hospital Saint-Antoine.
Vaccination against COVID-19: Where do we stand ? Read More »